PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)	Bacterial Infections and Mycoses, Enterobacteriaceae Infections, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, bacterial infectious disease, bacterial infectious disease with sepsis, gram-negative bacterial infections	Recruiting	Phase 4	2025-08-01		NCT03671967

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Institutes of Health Research (CIHR)	339
Hadassah Medical Organization	53
Jewish General Hospital	27
McGill University Health Centre/Research Institute of the McGill University Health Centre	139
Meir Medical Center	23
Rabin Medical Center	33
Rambam Health Care Campus	34
Soroka University Medical Center	10
Tel Aviv Medical Center	10
The Chaim Sheba Medical Center	6
University of Modena and Reggio Emilia	24

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Eastern Health	St. John's	Canada	1
Hadassah Medical Center	Jerusalem	Israel	24
Jewish Genral Hospital	Montreal	Canada	1
Kingston General Hospital	Kingston	Canada	7
McGill University Health Centre	Montreal, Quebec	Canada	1
Meir Medical Center	Kfar Saba	Israel	29
Rabin Medical Center, Beilinson Campus	Petah Tikva	Israel	1
Rambam Health Care Campus	Haifa	Israel	1
Sanz Medical Center-Laniado Hospital	Netanya	Israel	1
Sheba Medical Center (Tel HaShomer)	Tel Aviv	Israel	1
Soroka Medical Center	Beersheba	Israel	14
Sourasky Medical Center	Tel Aviv	Israel	7
Surrey Memorial Hospital - Fraser Health Authority	Surrey	Canada	1
University of Calgary, Cumming School of Medicine, O'Brien Institute for Public Health	Calgary	Canada	1